Standard

Long-Term Outcomes of Drug-Refractory Atrial Fibrillation After Atrioventricular Node Ablation Combined with Implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D). / Akhyt, Bagdat A.; Berkinbaev, Salim F.; Lozhkina, Natalya G. et al.

In: Journal of Clinical Medicine, Vol. 14, No. 24, 8938, 18.12.2025.

Research output: Contribution to journalArticlepeer-review

Harvard

Akhyt, BA, Berkinbaev, SF, Lozhkina, NG, Artemenko, SN, Zyatkov, NY, Krivorotko, OI, Koshumbayeva, KM, Pashimov, MO, Tuleutayev, RM & Kultanova, EB 2025, 'Long-Term Outcomes of Drug-Refractory Atrial Fibrillation After Atrioventricular Node Ablation Combined with Implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D)', Journal of Clinical Medicine, vol. 14, no. 24, 8938. https://doi.org/10.3390/jcm14248938

APA

Akhyt, B. A., Berkinbaev, S. F., Lozhkina, N. G., Artemenko, S. N., Zyatkov, N. Y., Krivorotko, O. I., Koshumbayeva, K. M., Pashimov, M. O., Tuleutayev, R. M., & Kultanova, E. B. (2025). Long-Term Outcomes of Drug-Refractory Atrial Fibrillation After Atrioventricular Node Ablation Combined with Implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D). Journal of Clinical Medicine, 14(24), [8938]. https://doi.org/10.3390/jcm14248938

Vancouver

Author

BibTeX

@article{9fab987d66314cd1af2bc2d9e1764bad,
title = "Long-Term Outcomes of Drug-Refractory Atrial Fibrillation After Atrioventricular Node Ablation Combined with Implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D)",
abstract = "Objective: In this study, we aimed to determine the most significant risk factors for 5-year mortality in patients with paroxysmal and persistent drug-refractory tachysystolic atrial fibrillation after undergoing atrioventricular node ablation (AVNA) in combination with the implantation of a permanent three-chamber pacemaker with an implantable cardioverter–defibrillator function (CRT-D). Methods: This prospective single-center cohort study included 101 patients with chronic heart failure (mean age 62 ± 15.5 years; 70.3% male) with paroxysmal or persistent drug-refractory atrial fibrillation who underwent atrioventricular node ablation and CRT-D implantation. All patients received optimal medical therapy before and after undergoing the procedure. Predictors of 5-year mortality were assessed using exploratory machine-learning methods, including random forest and Shapley additive explanations. Results: During 5-year follow-up, 13 cardiovascular deaths were recorded. Five key predictors of mortality were identified: left ventricular ejection fraction, 6 min walk distance, mean pulmonary artery pressure, systolic relaxation coefficient, and degree of mitral regurgitation. The exploratory predictive model showed high accuracy (92%) in terms of classifying the outcomes. Conclusions: Atrioventricular node ablation (AVNA) combined with CRT-D was associated with the observed long-term clinical outcomes observed in patients with drug-refractory tachysystolic atrial fibrillation. The exploratory machine learning analysis identified key mortality-associated factors, which may support future efforts in personalized risk stratification and hypothesis generation. The combination of AVNA and CRT-D was associated with the observed long-term outcomes in this real-world cohort.",
keywords = "atrial fibrillation, atrioventricular node ablation, cardiac resynchronization therapy defibrillator (CRT-D), congestive heart failure, long-term mortality",
author = "Akhyt, {Bagdat A.} and Berkinbaev, {Salim F.} and Lozhkina, {Natalya G.} and Artemenko, {Sergey N.} and Zyatkov, {Nikolay Yu} and Krivorotko, {Olga I.} and Koshumbayeva, {Kulzida M.} and Pashimov, {Marat O.} and Tuleutayev, {Rustem M.} and Kultanova, {Elmira B.}",
note = "Long-Term Outcomes of Drug-Refractory Atrial Fibrillation After Atrioventricular Node Ablation Combined with Implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D) / B. A. Akhyt, S. F. Berkinbaev, N. G. Lozhkina [et al.] // Journal of Clinical Medicine. – 2025. – Vol. 14. - No. 24. – P. 8938. – DOI 10.3390/jcm14248938. – EDN AMBFGC. The work was performed according to the Government research assignment for Sobolev Institute of Mathematics SB RAS, project FWNF-2024-0002 “Inverse ill-posed problems and machine learning in biological, socio-economic and ecological processes”.",
year = "2025",
month = dec,
day = "18",
doi = "10.3390/jcm14248938",
language = "English",
volume = "14",
journal = "Journal of Clinical Medicine",
issn = "2077-0383",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "24",

}

RIS

TY - JOUR

T1 - Long-Term Outcomes of Drug-Refractory Atrial Fibrillation After Atrioventricular Node Ablation Combined with Implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D)

AU - Akhyt, Bagdat A.

AU - Berkinbaev, Salim F.

AU - Lozhkina, Natalya G.

AU - Artemenko, Sergey N.

AU - Zyatkov, Nikolay Yu

AU - Krivorotko, Olga I.

AU - Koshumbayeva, Kulzida M.

AU - Pashimov, Marat O.

AU - Tuleutayev, Rustem M.

AU - Kultanova, Elmira B.

N1 - Long-Term Outcomes of Drug-Refractory Atrial Fibrillation After Atrioventricular Node Ablation Combined with Implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D) / B. A. Akhyt, S. F. Berkinbaev, N. G. Lozhkina [et al.] // Journal of Clinical Medicine. – 2025. – Vol. 14. - No. 24. – P. 8938. – DOI 10.3390/jcm14248938. – EDN AMBFGC. The work was performed according to the Government research assignment for Sobolev Institute of Mathematics SB RAS, project FWNF-2024-0002 “Inverse ill-posed problems and machine learning in biological, socio-economic and ecological processes”.

PY - 2025/12/18

Y1 - 2025/12/18

N2 - Objective: In this study, we aimed to determine the most significant risk factors for 5-year mortality in patients with paroxysmal and persistent drug-refractory tachysystolic atrial fibrillation after undergoing atrioventricular node ablation (AVNA) in combination with the implantation of a permanent three-chamber pacemaker with an implantable cardioverter–defibrillator function (CRT-D). Methods: This prospective single-center cohort study included 101 patients with chronic heart failure (mean age 62 ± 15.5 years; 70.3% male) with paroxysmal or persistent drug-refractory atrial fibrillation who underwent atrioventricular node ablation and CRT-D implantation. All patients received optimal medical therapy before and after undergoing the procedure. Predictors of 5-year mortality were assessed using exploratory machine-learning methods, including random forest and Shapley additive explanations. Results: During 5-year follow-up, 13 cardiovascular deaths were recorded. Five key predictors of mortality were identified: left ventricular ejection fraction, 6 min walk distance, mean pulmonary artery pressure, systolic relaxation coefficient, and degree of mitral regurgitation. The exploratory predictive model showed high accuracy (92%) in terms of classifying the outcomes. Conclusions: Atrioventricular node ablation (AVNA) combined with CRT-D was associated with the observed long-term clinical outcomes observed in patients with drug-refractory tachysystolic atrial fibrillation. The exploratory machine learning analysis identified key mortality-associated factors, which may support future efforts in personalized risk stratification and hypothesis generation. The combination of AVNA and CRT-D was associated with the observed long-term outcomes in this real-world cohort.

AB - Objective: In this study, we aimed to determine the most significant risk factors for 5-year mortality in patients with paroxysmal and persistent drug-refractory tachysystolic atrial fibrillation after undergoing atrioventricular node ablation (AVNA) in combination with the implantation of a permanent three-chamber pacemaker with an implantable cardioverter–defibrillator function (CRT-D). Methods: This prospective single-center cohort study included 101 patients with chronic heart failure (mean age 62 ± 15.5 years; 70.3% male) with paroxysmal or persistent drug-refractory atrial fibrillation who underwent atrioventricular node ablation and CRT-D implantation. All patients received optimal medical therapy before and after undergoing the procedure. Predictors of 5-year mortality were assessed using exploratory machine-learning methods, including random forest and Shapley additive explanations. Results: During 5-year follow-up, 13 cardiovascular deaths were recorded. Five key predictors of mortality were identified: left ventricular ejection fraction, 6 min walk distance, mean pulmonary artery pressure, systolic relaxation coefficient, and degree of mitral regurgitation. The exploratory predictive model showed high accuracy (92%) in terms of classifying the outcomes. Conclusions: Atrioventricular node ablation (AVNA) combined with CRT-D was associated with the observed long-term clinical outcomes observed in patients with drug-refractory tachysystolic atrial fibrillation. The exploratory machine learning analysis identified key mortality-associated factors, which may support future efforts in personalized risk stratification and hypothesis generation. The combination of AVNA and CRT-D was associated with the observed long-term outcomes in this real-world cohort.

KW - atrial fibrillation

KW - atrioventricular node ablation

KW - cardiac resynchronization therapy defibrillator (CRT-D)

KW - congestive heart failure

KW - long-term mortality

UR - https://www.scopus.com/pages/publications/105026017124

UR - https://elibrary.ru/item.asp?id=88251816

UR - https://www.mendeley.com/catalogue/e814cdc7-e468-3258-b822-3bce88aa629d/

U2 - 10.3390/jcm14248938

DO - 10.3390/jcm14248938

M3 - Article

VL - 14

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

SN - 2077-0383

IS - 24

M1 - 8938

ER -

ID: 74603868